Human Services

U.S. Department of Health and Human Services September 2019 Printer Friendly Version in PDF Format (61 PDF pages)

Non-fatal opioid overdose (NFOO) is a significant cause of opioid-related morbidity in the United States. As the number of NFOOs continues to grow, it is important to understand the short- and long-term consequences of NFOO.

States have begun to collect and post information on bed availability (i.e., create bed registries or bed tracking systems) as a tool for providers, patients, and caregivers to identify open beds more efficiently.

People with behavioral health conditions such as serious mental illness (SMI) and substance use disorders (SUDs), including opioid use disorder (OUD), are 3-6 times more likely than the general population to be represented in the criminal justice system.

While child support agencies have acknowledged the rise in substance use among noncustodial parents, there is little to no research that has looked specifically at this population with substance use issues and the effects of that use on child support outcomes, including payment patterns and arrears accumulation.

This document provides highlights of the evaluation of the Support and Services at Home (SASH) program for the first years of the program (2010-2016). The SASH program in Vermont is a promising approach to providing support services and care coordination to older adults and individuals with disabilities, using affordable housing properties as a platform for service delivery.

This paper describes the primary features of the SASH program and summarizes the main findings of the evaluation to date.

ABSTRACT This report was included as Appendix B of "Psychosocial Supports in Medication-Assisted Treatment: Site Visit Findings and Conclusions." That report's purpose was to gain a better understanding of the role and range of different models of psychosocial support in medication-assisted treatment for opioid use disorder.

Westat Printer Friendly Version in PDF Format (3 PDF pages)

The purpose of this report is to gain a better understanding of the role and range of different models of psychosocial support in medication-assisted treatment for opioid use disorder.